Furthermore, CD133+ liver cancer cells enhance their invasiveness through epithelial-mesenchymal transition (EMT) and promote distant metastasis by secreting angiogenic factors such as VEGF (23), significantly increasing the risk of early recurrence. Here, VEGFA is linked to liver cancer.